Express News | Novo-Nordisk A/S: Confident in China's economic outlook and development in China, willing to continue focusing on the Chinese market.

Breakings09:41

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

MT Newswires00:17

U.S. stocks are experiencing fluctuations | Novo-Nordisk A/S (NVO.US) is rising nearly 2% against the trend while developing weight-loss drugs using AI.

On Friday, Novo-Nordisk A/S (NVO.US) rose nearly 2% against the trend, closing at $86.77.

Zhitong FinanceJan 10 23:11

Novo Holdings Invests in $200M Series A for Windward Bio Launch to Advance Long-acting Treatments for Asthma and COPD

PR NewswireJan 10 22:29

HIMS Downgraded, Agilon Upgraded at Citi in 2025 Health Tech Review

Seeking AlphaJan 10 21:56

Novo Nordisk Still a Buy, But Patience May Be Needed -- Market Talk

WSJJan 10 21:41